Edition:
United Kingdom

People: Sinopharm Group Co Ltd (1099.HK)

1099.HK on Hong Kong Stock

27.15HKD
19 Aug 2019
Change (% chg)

HK$0.40 (+1.50%)
Prev Close
HK$26.75
Open
HK$27.25
Day's High
HK$27.80
Day's Low
HK$26.95
Volume
6,967,631
Avg. Vol
6,180,512
52-wk High
HK$41.05
52-wk Low
HK$25.70

She, Lulin 

Mr. She Lulin is Non-Executive Director of Sinopharm Group Co., Ltd., with effect from 22 September 2014. He joined the Group as a non-executive Director on 16 January 2003. He was the vice Chairman and has served as the Chairman of from August 2007 to November 2013. He has around 34 years of working experience, over 31 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. She obtained a bachelor’s degree in science, majoring in Pharmacy, from Nanjing Pharmaceutical Institution (currently known as China Pharmaceutical University) in July 1982 and a master’s degree in business administration for executives from Tsinghua University in July 2005. Mr. She was previously the deputy head of the office, assistant to the general manager, deputy general manager and general manager of China National Pharmaceutical Group Guangzhou Corporation from August 1982 to August 1996. Mr. She was also the vice chairman of the board of directors and general manager of CNPGC from December 1998 to October 2004. Mr. She was a director, general manager and the secretary of Party Committee of CNPGC from October 2004 to October 2009. He was the vice chairman of the board of directors, general manager and deputy secretary of Party Committee of CNPGC since October 2009. Mr. She has been the chairman of the board of directors and legal representative of Sinopharm Industrial Investment Co., Ltd. from July 2008 to November 2013. Mr. She was the chairman of the board of directors of China National Medicines Corporation Ltd. from December 1998 to January 2001.

Basic Compensation

Total Annual Compensation, CNY 5,766,000
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY 110,000
Fiscal Year Total, CNY 5,876,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Zhiming Li

6,572,000

Yong Liu

7,489,000

Qiyu Chen

--

Xiuchang Jiang

--

Maisong Cai

--

Jun Lu

--
As Of  31 Dec 2017